In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Design Therapeutics Inc’s stock clocked out at $4.08, up 2.77% from its previous closing price of $3.97. In other words, the price has increased by $2.77 from its previous closing price. On the day, 0.14 million shares were traded. DSGN stock price reached its highest trading level at $4.19 during the session, while it also had its lowest trading level at $3.985.
Ratios:
To gain a deeper understanding of DSGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 34.61 and its Current Ratio is at 34.61. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 07, 2024, Upgraded its rating to Overweight and sets its target price to $12 from $6 previously.
On November 14, 2023, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $42 to $6.
Wedbush Downgraded its Outperform to Neutral on August 15, 2023, whereas the target price for the stock was revised from $19 to $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 18 ’24 when Prasad Deepa sold 3,806 shares for $6.27 per share. The transaction valued at 23,864 led to the insider holds 20,000 shares of the business.
William Arsani sold 814,874 shares of DSGN for $3,463,214 on Aug 09 ’24. The Director now owns 0 shares after completing the transaction at $4.25 per share. On Aug 09 ’24, another insider, Logos SPV 1 LP, who serves as the Director of the company, bought 814,874 shares for $4.24 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 231013680 and an Enterprise Value of -20538170.
Stock Price History:
The Beta on a monthly basis for DSGN is 1.78, which has changed by 0.53962266 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, DSGN has reached a high of $7.77, while it has fallen to a 52-week low of $2.26. The 50-Day Moving Average of the stock is -24.41%, while the 200-Day Moving Average is calculated to be -16.96%.
Shares Statistics:
It appears that DSGN traded 174.29K shares on average per day over the past three months and 121160 shares per day over the past ten days. A total of 56.62M shares are outstanding, with a floating share count of 30.85M. Insiders hold about 44.54% of the company’s shares, while institutions hold 43.26% stake in the company. Shares short for DSGN as of 1738281600 were 3155000 with a Short Ratio of 18.10, compared to 1735603200 on 2921754. Therefore, it implies a Short% of Shares Outstanding of 3155000 and a Short% of Float of 12.34.
